Business
Here’s why the Kazia Therapeutics (ASX:KZA) share price got a 6% boost today
Image Source: Getty Images
Shares in Kazia Therapeutics Ltd (ASX: KZA) lifted today after news its investigational drug Paxalisib will be part of another study for the treatment of brain cancer. At market close, the Kazia share price is $1.40 – 6.87% higher than its previous…
Continue Reading
-
General7 hours agoRSL NSW president Mick Bainbridge and three board members resign in wake of 7.30 investigation into conflicts of interest
-
General19 hours agoNewsCorp executive warns AI firms are asking Australia to ‘surrender our stories’
-
General23 hours agoTrio of scientists win Nobel Prize in Chemistry for ‘development of metal-organic frameworks’
-
Noosa News20 hours agoMother’s heartache after daughter Jayda Cook, 26, found dead on her birthday in Sydney apartment